BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30889096)

  • 1. Safety and feasibility of estrogen receptor-β targeted phytoSERM formulation for menopausal symptoms: phase 1b/2a randomized clinical trial.
    Schneider LS; Hernandez G; Zhao L; Franke AA; Chen YL; Pawluczyk S; Mack WJ; Brinton RD
    Menopause; 2019 Aug; 26(8):874-884. PubMed ID: 30889096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective analysis of phytoSERM for management of menopause-associated vasomotor symptoms and cognitive decline: a pilot study on pharmacogenomic effects of mitochondrial haplogroup and APOE genotype on therapeutic efficacy.
    Wang Y; Hernandez G; Mack WJ; Schneider LS; Yin F; Brinton RD
    Menopause; 2020 Jan; 27(1):57-65. PubMed ID: 31567873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and safety profile of single-dose administration of an estrogen receptor β-selective phytoestrogenic (phytoSERM) formulation in perimenopausal and postmenopausal women.
    Hernandez G; Zhao L; Franke AA; Chen YL; Mack WJ; Brinton RD; Schneider LS
    Menopause; 2018 Feb; 25(2):191-196. PubMed ID: 28926513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of dose, frequency of administration, and equol production on efficacy of isoflavones for menopausal hot flashes: a pilot randomized trial.
    Crawford SL; Jackson EA; Churchill L; Lampe JW; Leung K; Ockene JK
    Menopause; 2013 Sep; 20(9):936-45. PubMed ID: 23511704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoflavone supplement composition and equol producer status affect gene expression in adipose tissue: a double-blind, randomized, placebo-controlled crossover trial in postmenopausal women.
    van der Velpen V; Geelen A; Hollman PC; Schouten EG; van 't Veer P; Afman LA
    Am J Clin Nutr; 2014 Nov; 100(5):1269-77. PubMed ID: 25332325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial.
    Pawlowski JW; Martin BR; McCabe GP; McCabe L; Jackson GS; Peacock M; Barnes S; Weaver CM
    Am J Clin Nutr; 2015 Sep; 102(3):695-703. PubMed ID: 26245807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical investigation of RAD1901, a novel estrogen receptor ligand, for the treatment of postmenopausal vasomotor symptoms: a phase 2 randomized, placebo-controlled, double-blind, dose-ranging, proof-of-concept trial.
    Hattersley G; Harris AG; Simon JA; Constantine GD
    Menopause; 2017 Jan; 24(1):92-99. PubMed ID: 27575546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production.
    Hall WL; Vafeiadou K; Hallund J; Bugel S; Reimann M; Koebnick C; Zunft HJ; Ferrari M; Branca F; Dadd T; Talbot D; Powell J; Minihane AM; Cassidy A; Nilsson M; Dahlman-Wright K; Gustafsson JA; Williams CM
    Am J Clin Nutr; 2006 Mar; 83(3):592-600. PubMed ID: 16522905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of brain mitochondrial function by S-equol and R/S-equol estrogen receptor β-selective phytoSERM treatments.
    Yao J; Zhao L; Mao Z; Chen S; Wong KC; To J; Brinton RD
    Brain Res; 2013 Jun; 1514():128-41. PubMed ID: 23428542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor-mediated effects of isoflavone supplementation were not observed in whole-genome gene expression profiles of peripheral blood mononuclear cells in postmenopausal, equol-producing women.
    van der Velpen V; Geelen A; Schouten EG; Hollman PC; Afman LA; van 't Veer P
    J Nutr; 2013 Jun; 143(6):774-80. PubMed ID: 23616509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production.
    Hall WL; Vafeiadou K; Hallund J; Bügel S; Koebnick C; Reimann M; Ferrari M; Branca F; Talbot D; Dadd T; Nilsson M; Dahlman-Wright K; Gustafsson JA; Minihane AM; Williams CM
    Am J Clin Nutr; 2005 Dec; 82(6):1260-8; quiz 1365-6. PubMed ID: 16332659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A natural S-equol supplement alleviates hot flushes and other menopausal symptoms in equol nonproducing postmenopausal Japanese women.
    Aso T; Uchiyama S; Matsumura Y; Taguchi M; Nozaki M; Takamatsu K; Ishizuka B; Kubota T; Mizunuma H; Ohta H
    J Womens Health (Larchmt); 2012 Jan; 21(1):92-100. PubMed ID: 21992596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized double-blind placebo-controlled trial of a Chinese herbal medicine preparation (Jiawei Qing'e Fang) for hot flashes and quality of life in perimenopausal women.
    Xia Y; Zhao Y; Ren M; Zhang J; Wang Y; Chang Y; Fu S; Fan G; Zhu Y; Huang Y; Gao X
    Menopause; 2012 Feb; 19(2):234-44. PubMed ID: 22089177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-equol: a potential nonhormonal agent for menopause-related symptom relief.
    Utian WH; Jones M; Setchell KD
    J Womens Health (Larchmt); 2015 Mar; 24(3):200-8. PubMed ID: 25692726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and women.
    Gleason CE; Carlsson CM; Barnet JH; Meade SA; Setchell KD; Atwood CS; Johnson SC; Ries ML; Asthana S
    Age Ageing; 2009 Jan; 38(1):86-93. PubMed ID: 19054783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 microg) in women with postmenopausal symptoms: updated analysis of three randomized, controlled trials.
    Rowan JP; Simon JA; Speroff L; Ellman H
    Clin Ther; 2006 Jun; 28(6):921-32. PubMed ID: 16860174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phytoestrogens for menopausal vasomotor symptoms.
    Lethaby A; Marjoribanks J; Kronenberg F; Roberts H; Eden J; Brown J
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD001395. PubMed ID: 24323914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of whole soy and isoflavone daidzein on menopausal symptoms in equol-producing Chinese postmenopausal women.
    Liu ZM; Ho SC; Woo J; Chen YM; Wong C
    Menopause; 2014 Jun; 21(6):653-60. PubMed ID: 24149925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study on the effects of S-equol compared to soy isoflavones on menopausal hot flash frequency.
    Jenks BH; Iwashita S; Nakagawa Y; Ragland K; Lee J; Carson WH; Ueno T; Uchiyama S
    J Womens Health (Larchmt); 2012 Jun; 21(6):674-82. PubMed ID: 22409590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms.
    Ferrari A
    J Obstet Gynaecol Res; 2009 Dec; 35(6):1083-90. PubMed ID: 20025635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.